A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)

Published 2013 View Full Article

Authors

Keywords

Journal

CLINICAL THERAPEUTICS

Volume 35, Issue 9, Pages 1400-1411.e3

Publisher

Elsevier BV

Online

2013-08-31

DOI

10.1016/j.clinthera.2013.07.420

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Ask a Question. Answer a Question.